Sri Narasus Coffee Aims for 1000 Crore Revenue in Five Years Plans Expansion into Karnataka Kerala and Andhra Pradesh Canadas Big Banks Expected to Report Solid Q2 Earnings but Outlook Takes Center Stage Amid Softening Economy Colombia Violence Claims at Least 52 Lives Raising Security and Economic Concerns Surge in LongDated Treasury Yields Prompts Bond Investors to Reassess RiskFree Assumptions ECB Signals No Urgency to Counter Market Speculation on June Rate Hike RBI Approves ICICI Bank CEO Sandeep Bakhshis Reappointment for Two More Years authID Inc Q1 2026 Earnings EPS Loss of 028 as Revenue Not Reported Stock Declines 168 Public Policy Holding Company Inc PPHC Q4 2025 Earnings EPS Shatters Estimates by 20 as Stock Slips VirnetX VHC Q2 2025 Earnings Narrowing Loss on Zero Revenue Stock Edges Lower Coeur Mining CDE Q1 2026 Earnings EPS Misses Street Estimates as Costs Pressure Bottom Line ADT Q1 2026 Earnings EPS Surpasses Estimates Despite Stock Decline KRRO Q1 2026 Earnings EPS Beat Driven by Expense Management ProAssurance PRA Holds Steady Near 2462 as Market Awaits Catalysts Celularity CELU Edges Higher Navigating Key Resistance at 097 Context Therapeutics CNTX Surges Over 8 Amid Renewed Buying Interest Above Key Support BlackRock Science and Technology Trust BST Advances 155 as Growth Stocks Find Favor Citizens Community Bancorp CZWI Edges Lower as Stock Holds Above Key Support AI Economy Reshapes Labor Demand ATT CEO Highlights BlueCollar Worker Shortage AFGE Q1 2026 Earnings EPS Misses Estimates Amid Stable Bond Performance BioLife Solutions BLFS Gains Ground Moving Toward Key Resistance at 2573 Murphy Oil MUR Edges Higher Amid Stabilizing Crude Prices Faces Key Resistance at 3786 GT Biopharma GTBP Maintains Support Zone Amid Modest Uptick SEALSQ Corp LAES Rallies 336 Key Levels to Watch Monopar Therapeutics MNPR Slips Slightly While Holding Key Technical Levels First US Bancshares Inc FUSB Holds Steady at 160 Consolidation Phase Ahead Gauzy Ltd GAUZ Slides 135 as Stock Hovers Near Key Support Addex Therapeutics ADXN Slips 229 as Stock Hovers Near Key Support